PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
23335124-1	2013	We assessed surface coating with carbodiimide derivatized hyaluronic acid combined with lubricin (cd-HA-Lubricin) as a way to improve extrasynovial tendon surface quality and, consequently, the functional results in flexor tendon reconstruction, using a canine in vivo model.	Carbodiimides	33-45	proteoglycan 4	Canis lupus familiaris	104-112	
26177854-1	2016	The purpose of the study was to test a novel treatment that carbodiimide-derivatized-hyaluronic acid-lubricin (cd-HA-lubricin) combined cell-based therapy in an immobilized flexor tendon repair in a canine model.	Carbodiimides	60-72	proteoglycan 4	Canis lupus familiaris	101-109	
26177854-1	2016	The purpose of the study was to test a novel treatment that carbodiimide-derivatized-hyaluronic acid-lubricin (cd-HA-lubricin) combined cell-based therapy in an immobilized flexor tendon repair in a canine model.	Carbodiimides	60-72	proteoglycan 4	Canis lupus familiaris	117-125	
24445876-7	2014	RESULTS: Allograft tendons treated with carbodiimide-derivatized hyaluronic acid-lubricin had decreased adhesions at the proximal tendon/graft repair and within the flexor sheath, improved digit function, and increased graft gliding ability.	Carbodiimides	40-52	proteoglycan 4	Canis lupus familiaris	81-89	
24445876-10	2014	CONCLUSIONS: Carbodiimide-derivatized hyaluronic acid-lubricin treatment of tendon allograft improves digit functional outcomes after flexor tendon reconstruction.	Carbodiimides	13-25	proteoglycan 4	Canis lupus familiaris	54-62	
20516321-1	2010	BACKGROUND: Tendon surface modification with a synthetic biopolymer, carbodiimide-derivatized hyaluronic acid and gelatin with the addition of lubricin (CHL), has been shown to reduce gliding resistance after tendon repair in an in vitro model.	Carbodiimides	69-81	proteoglycan 4	Canis lupus familiaris	143-151